CKD Corporation

As of March 31, 2026, CKD Corporation carries a market capitalization of 285.39B, placing it among publicly traded companies globally. Its enterprise value stands at 277.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CKD Corporation's next confirmed earnings release is scheduled for November 13, 2026.

As of March 31, 2026, CKD Corporation has 66.84M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, CKD Corporation maintains a current ratio of 3.43, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 23, 2026, CKD Corporation's stock has gained approximately 37.21% over the past 52 weeks. The 50-day moving average sits at 5,413.10, while the 200-day moving average is 5,524.33.

As of March 31, 2026, CKD Corporation holds 42.84B in cash and equivalents against 34.60B in total debt, resulting in a net debt position of -9.28B. Total book value stands at 153.54B, with working capital of 102.31B providing operational flexibility.

CKD Corporation's most recent stock split took place on March 28, 1988 with a 10:11 split ratio.